Authors:
Cannon, CP
McCabe, CH
Wilcox, RG
Langer, A
Caspi, A
Berink, P
Lopez-Sendon, J
Toman, J
Charlesworth, A
Anders, RJ
Alexander, JC
Skene, A
Braunwald, E
Citation: Cp. Cannon et al., Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial, CIRCULATION, 102(2), 2000, pp. 149-156